Abstract
Facial volumetric restoration, augmentation, and contouring with injectable products such as hyaluronic acid dermal fillers are exceedingly popular procedures in the minimally invasive and non-surgical era. These agents are traditionally used to merely fill lines and wrinkles, however, with the evolution of products and enhanced knowledge, these agents can be used for total facial rejuvenation. Although hyaluronic acid dermal fillers are the most popular agents globally, there are other filling/volumising agents available internationally with their own specific characteristics and indications for use. With increased globalisation, aesthetic clinicians may see patients who have had treatments with filling agents that they are not familiar with. Dermal fillers can be categorised in many ways, including according to the source of the product (biologic or synthetic), longevity within the tissues (temporary, semi-permanent, or permanent), the biomechanics of filling (volumetric, structural, or fibroplastic), or according to their bio-stimulatory effects. It is paramount to understand that injection of any filling agent into the facial tissues can prompt a local tissue injury response. It is therefore crucial for aesthetic clinicians to become familiar with the characteristics of commonly available products, to facilitate informed decision making and treatment planning. Correct product should be chosen based on patient factors, indications and contraindications for use, and the knowledge and expertise of the physician.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
de Jesus LH, et al. Location of injected polymethylmethacrylate microspheres influences the onset of late adverse effects: an experimental and histopathologic study. Clin Cosmet Investig Dermatol. 2015;8:431–6.
Gilbert E, et al. The basic science of dermal fillers: past and present Part II: adverse effects. J Drugs Dermatol. 2012;11(9):1069–77.
Fagien S, Klein AW. A brief overview and history of temporary fillers: evolution, advantages, and limitations. Plast Reconstr Surg. 2007;120(6S):8S–16S.
Klein AW, Elson ML. The history of substances for soft tissue augmentation. Dermatol Surg. 2000;26(12):1096–105.
Rapaport MJ, Vinnik C, Zarem H. Injectable silicone: cause of facial nodules, cellulitis, ulceration, and migration. Aesthet Plast Surg. 1996;20(3):267–76.
Achauer BM. A serious complication following medical-grade silicone injection of the face. Plast Reconstr Surg. 1983;71(2):251–3.
Mastruserio DN, Pesqueira MJ, Cobb MW. Severe granulomatous reaction and facial ulceration occurring after subcutaneous silicone injection. J Am Acad Dermatol. 1996;34(5):849–52.
Bon A, Eichmann A. Serious long-term complication following silicone injection of the face. Dermatology. 1993;187(4):286–7.
Gilbert E, Hui A, Waldorf HA. The basic science of dermal fillers: past and present Part I: background and mechanisms of action. J Drugs Dermatol. 2012;11(9):1059–68.
Henly DR, et al. Particulate silicone for use in periurethral injections: local tissue effects and search for migration. J Urol. 1995;153(6):2039–43.
Dewan P, et al. Migration of particulate silicone after ureteric injection with silicone. BJU Int. 2000;85(4)
Dolwick MF, Aufdemorte TB. Silicone-induced foreign body reaction and lymphadenopathy after temporomandibular joint arthroplasty. Oral Surg Oral Med Oral Pathol. 1985;59(5):449–52.
Hatanaka S, et al. Induction of malignant fibrous histiocytoma in female Fisher rats by implantation of cyanoacrylate, zirconia, polyvinyl chloride or silicone. In Vivo (Athens, Greece). 1993;7(2):111–5.
Coleman SR. Injectable silicone returns to the United States. Aesthet Surg J. 2001;21(6):576–8.
Moon SH, et al. Comparative study of the effectiveness and safety of porcine and bovine atelocollagen in Asian nasolabial fold correction. J Plast Surg Hand Surg. 2015;49(3):147–52.
Pollack SV. Some new injectable dermal filler materials: hylaform, restylane, and artecoll. J Cutan Med Surg. 1999;3(4_suppl):S4-27–35.
Downie J, et al. A double-blind, clinical evaluation of facial augmentation treatments: a comparison of PRI 1, PRI 2, Zyplast and Perlane. J Plast Reconstr Aesthet Surg. 2009;62(12):1636–43.
Lee JH, et al. Efficacy and safety of porcine collagen filler for nasolabial fold correction in Asians: a prospective multicenter, 12 months follow-up study. J Korean Med Sci. 2014;29(Suppl 3):S217–21.
Owens JM. Soft tissue implants and fillers. Otolaryngol Clin N Am. 2005;38(2):361–9.
Saray A. Porcine dermal collagen (permacol) for facial contour augmentation: preliminary report. Aesthet Plast Surg. 2003;27(5):368–75.
De Boulle K, et al. Lip augmentation and contour correction with a ribose cross-linked collagen dermal filler. J Drugs Dermatol. 2009;8(3 Suppl):1–8.
Braun M, Braun S. Nodule formation following lip augmentation using porcine collagen-derived filler. J Drugs Dermatol. 2008;7(6):579–81.
Cassuto D. The use of dermicol-P35 dermal filler for nonsurgical rhinoplasty. Aesthetic Surg J. 2009;29(3_Suppl):S22–4.
Sánchez-Carpintero I, Candelas D, Ruiz-Rodríguez R. Dermal fillers: types, indications, and complications. Actas Dermo-Sifiliográficas (English Edition). 2010;101(5):381–93.
Johl SS, Burgett RA. Dermal filler agents: a practical review. Curr Opin Ophthalmol. 2006;17(5):471–9.
Vaishya R, Chauhan M, Vaish A. Bone cement. J Clin Orthop Trauma. 2013;4(4):157–63.
Zafar MS. prosthodontic applications of polymethyl methacrylate (PMMA): an update. Polymers. 2020;12(10):2299.
Lemperle G, Gauthier-Hazan N, Lemperle M. PMMA-Microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthet Plast Surg. 1998;22(5):356–65.
Lee YB, et al. Safety and efficacy of a novel injectable filler in the treatment of nasolabial folds: polymethylmethacrylate and cross-linked dextran in hydroxypropyl methylcellulose. J Cosmet Laser Ther. 2014;16(4):185–90.
Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29(6):573–87. discussion 587
Kim KJ, et al. Artecoll granuloma: a rare adverse reaction induced by microimplant in the treatment of neck wrinkles. Dermatol Surg. 2004;30(4):545–7.
Requena C, et al. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol. 2001;23(3):197–202.
Christensen L, et al. Adverse reactions to injectable soft tissue permanent fillers. Aesthet Plast Surg. 2005;29(1):34–48.
Branco de Castro AC, et al. Extensive facial necrosis after infiltration of polymethylmethacrylate. Braz J Otorhinolaryngol. 2007;73(6):850.
Silva MTT, Curi AL. Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr. 2004;62(3B):873–4.
Salles AG, et al. Complications after polymethylmethacrylate injections: report of 32 cases. Plast Reconstr Surg. 2008;121(5):1811–20.
Friedmann DP, Kurian A, Fitzpatrick RE. Delayed granulomatous reactions to facial cosmetic injections of polymethylmethacrylate microspheres and liquid injectable silicone: a case series. J Cosmet Laser Ther. 2016;18(3):170–3.
Haneke E. Polymethyl methacrylate microspheres in collagen. Semin Cutan Med Surg. 2004;23(4):227–32.
Manfro AG, et al. Case reports of hypercalcemia and chronic renal disease due to cosmetic injections of polymethylmethacrylate (PMMA). J Bras Nefrol. 2020.
Tachamo N, et al. Hypercalcemia associated with cosmetic injections: a systematic review. Eur J Endocrinol. 2018;178(4):425–30.
Goldman A, Staub H, Wollina U. Hypercalcemia due to polymethylmethacrylate injections? (Literature review and case reports). Georgian Med News. 2018;282:17–20.
Jacovella PF. Use of calcium hydroxylapatite (Radiesse) for facial augmentation. Clin Interv Aging. 2008;3(1):161–74.
Flaharty P. Radiance. Facial Plast Surg. 2004;20(2):165–9.
Emer J, Sundaram H. Aesthetic applications of calcium hydroxylapatite volumizing filler: an evidence-based review and discussion of current concepts: (part 1 of 2). J Drugs Dermatol. 2013;12(12):1345–54.
Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite-based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006;118(3S):22S–30S.
Marmur ES, Phelps R, Goldberg DJ. Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther. 2004;6(4):223–6.
Zerbinati N, et al. Microscopic and ultrastructural evidences in human skin following calcium hydroxylapatite filler treatment. Arch Dermatol Res. 2017;309(5):389–96.
Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology. 2001;57(3):434–8.
Stein J, et al. Histopathologic study of alternative substances for vocal fold medialization. Ann Otol Rhinol Laryngol. 2000;109(2):221–6.
Bass LS, et al. Calcium hydroxylapatite (radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J. 2010;30(2):235–8.
Goldberg DJ, Amin S, Hussain M. Acne scar correction using calcium hydroxylapatite in a carrier-based gel. J Cosmet Laser Ther. 2006;8(3):134–6.
Shumaker PR, et al. Calcium hydroxylapatite tissue filler discovered 6 years after implantation into the nasolabial fold: case report and review. Dermatol Surg. 2009;35(s1):375–9.
Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008;34(Suppl 1):S9–15.
Sadick NS, Katz BE, Roy D. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatol Surg. 2007;33(Suppl 2):S122–6. discussion S126–7
Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg. 2005;55(1):30–5. discussion 35
Sung MS, et al. Ocular ischemia and ischemic oculomotor nerve palsy after vascular embolization of injectable calcium hydroxylapatite filler. Ophthalmic Plast Reconstr Surg. 2010;26(4):289–91.
Glass LRD, Choi CJ, Lee NG. Orbital complication following calcium hydroxylapatite filler injection. Ophthalmic Plast Reconstr Surg. 2017;33(3S):S16–7.
Carruthers A, et al. Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV–associated facial lipoatrophy and correction of nasolabial folds. Dermatol Surg. 2008;34(s1):S78–84.
Feeney JN, Fox JJ, Akhurst T. Radiological impact of the use of calcium hydroxylapatite dermal fillers. Clin Radiol. 2009;64(9):897–902.
Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials. 2000;21(23):2335–46.
Barrows T. Degradable implant materials: a review of synthetic absorbable polymers and their applications. Clin Mater. 1986;1(4):233–57.
Gunatillake PA, Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater. 2003;5(1):1–16.
Rotunda AM, Narins RS. Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther. 2006;19(3):151–8.
Lowe N. Dispelling the myth: appropriate use of poly-l-lactic acid and clinical considerations. J Eur Acad Dermatol Venereol. 2006;20:2–6.
Lombardi T, et al. Orofacial granulomas after injection of cosmetic fillers. Histopathologic and clinical study of 11 cases. J Oral Pathol Med. 2004;33(2):115–20.
Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52(2):233–9.
Vert M, Li S, Garreau H. Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomater Sci Polym Ed. 1995;6(7):639–49.
Brady JM, et al. Resorption rate, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat. J Biomed Mater Res. 1973;7(2):155–66.
Pietrzak WS, Sarver DR, Verstynen ML. Bioabsorbable polymer science for the practicing surgeon. J Craniofac Surg. 1997;8(2):87–91.
Cutright DE, Hunsuck EE. Tissue reaction to the biodegradable polylactic acid suture. Oral Surg Oral Med Oral Pathol. 1971;31(1):134–9.
Moyle G, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5(2):82–7.
Humble G, Mest D. Soft tissue augmentation using sculptra. Facial Plast Surg. 2004;20(2):157–63.
Mest D. Experience with injectable poly-L-lactic acid in clinical practice. Cosmet Dermatol. 2005;18(2):S2.
Valantin M-A, et al. Polylactic acid implants (New-Fill)® to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003;17(17):2471–7.
Vleggaar D. Soft-tissue augmentation and the role of poly-L-lactic acid. Plast Reconstr Surg. 2006;118(3 Suppl):46s–54s.
Sadick NS. Poly-l-lactic acid: a perspective from my practice. J Cosmet Dermatol. 2008;7(1):55–60.
Schierle CF, Casas LA. Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for restoration of soft tissue volume. Aesthet Surg J. 2011;31(1):95–109.
Narins RS. Minimizing adverse events associated with poly-l-lactic acid injection. Dermatol Surg. 2008;34(s1):S100–4.
Engelhard P, Humble G, Mest D. Safety of Sculptra: a review of clinical trial data. J Cosmet Laser Ther. 2005;7(3–4):201–5.
Lam SM, Azizzadeh B, Graivier M. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring. Plast Reconstr Surg. 2006;118(3 Suppl):55s–63s.
Beljaards RC, de Roos KP, Bruins FG. NewFill for skin augmentation: a new filler or failure? Dermatol Surg. 2005;31(7):772–7.
Roberts SAI, Arthurs BP. Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection. Ophthalmic Plast Reconstr Surg, 2012;28(3).
Christen M-O, Vercesi F. Polycaprolactone: How a well-known and futuristic polymer has become an innovative collagen-stimulator in esthetics. Clin Cosmet Investig Dermatol. 2020;13:31.
Woodruff MA, Hutmacher DW. The return of a forgotten polymer—polycaprolactone in the 21st century. Prog Polym Sci. 2010;35(10):1217–56.
Abedalwafa M, et al. Biodegradable poly-epsilon-caprolactone (PCL) for tissue engineering applications: a review. Rev Adv Mater Sci. 2013;34(2):123–40.
Zopf DA, et al. Treatment of severe porcine tracheomalacia with a 3-dimensionally printed, bioresorbable, external airway splint. JAMA Otolaryngol Head Neck Surg. 2014;140(1):66–71.
Kim JA, Van Abel D. Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler. J Cosmet Laser Ther. 2015;17(2):99–101.
Kim JS. Changes in dermal thickness in biopsy study of histologic findings after a single injection of polycaprolactone-based filler into the dermis. Aesthet Surg J. 2019;39(12):Np484–np494.
Lin SL, Christen MO. Polycaprolactone-based dermal filler complications: a retrospective study of 1111 treatments. J Cosmet Dermatol. 2020;19(8):1907–14.
Woodward SC, et al. The intracellular degradation of poly(epsilon-caprolactone). J Biomed Mater Res. 1985;19(4):437–44.
Heimowska A, Morawska M, Bocho-Janiszewska A. Biodegradation of poly (ε-caprolactone) in natural water environments. Pol J Chem Technol. 2017;19(1):120–6.
Figueiredo VM. A five-patient prospective pilot study of a polycaprolactone based dermal filler for hand rejuvenation. J Cosmet Dermatol. 2013;12(1):73–7.
Moers-Carpi MM, Sherwood S. Polycaprolactone for the correction of nasolabial folds: a 24-month, prospective, randomized, controlled clinical trial. Dermatol Surg. 2013;39(3 Pt 1):457–63.
Bae B, et al. Safety and long-term efficacy of forehead contouring with a polycaprolactone-based dermal filler. Dermatol Surg. 2016;42(11):1256–60.
de Melo F, et al. Recommendations for volume augmentation and rejuvenation of the face and hands with the new generation polycaprolactone-based collagen stimulator (Ellansé(®)). Clin Cosmet Investig Dermatol. 2017;10:431–40.
Lowe NJ, Ghanem AM. Volume restoration of hands with polycaprolactone by cannula delivery; a prospective single center consecutive case series evaluation. J Cosmet Laser Ther. 2020;22(2):55–9.
Galadari H, et al. A randomized, prospective, blinded, split-face, single-center study comparing polycaprolactone to hyaluronic acid for treatment of nasolabial folds. J Cosmet Dermatol. 2015;14(1):27–32.
Skrzypek E, et al. Granuloma as a complication of polycaprolactone-based dermal filler injection: ultrasound and histopathology studies. J Cosmet Laser Ther. 2019;21(2):65–8.
Or L, et al. Xanthelasma-like reaction to filler injection. Ophthalmic Plast Reconstr Surg, 2017;33(4).
Moon SY, et al. Foreign body reaction three years after injection with polycaprolactone (Ellanse®). Eur J Dermatol. 2017;27(5):549–51.
Tezel A, Fredrickson GH. The science of hyaluronic acid dermal fillers. J Cosmet Laser Ther. 2008;10(1):35–42.
Kablik J, et al. Comparative physical properties of hyaluronic acid dermal fillers. Dermatol Surg. 2009;35:302–12.
Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging. 2007;2(3):369.
Almond A. Hyaluronan. Cell Mol Life Sci. 2007;64(13):1591–6.
Monheit GD, Prather CL. Juvéderm: a hyaluronic acid dermal filler. J Drugs Dermatol. 2007;6(11):1091.
Ave MN, de Almeida Issa MC, Issa M, Tamura B. Hyaluronic Acid Dermal Filler: Physical Properties and Its Indications. Botulinum Toxins, Fillers and Related Substances. Clinical Approaches and Procedures in Cosmetic Dermatology. 2018;4:187–97.
Sundaram H, Michaels J. Rheological evaluation of the physical properties of hyaluronic acid dermal fillers. J Drugs Dermatol. 2011;10(9):974–80.
Sundaram H, Fagien S. Cohesive polydensified matrix hyaluronic acid for fine lines. Plast Reconstr Surg. 2015;136:149S–63S.
Sundaram H, Rohrich RJ, Liew S, Sattler G, Talarico S, Trévidic P, Molliard SG. Cohesivity of hyaluronic acid fillers: development and clinical implications of a novel assay, pilot validation with a five-point grading scale, and evaluation of six U.S. food and drug administration-approved fillers. Plast Reconstr Surg. 2015;136:678–86.
Choi MS. Basic rheology of dermal filler. Arch Plast Surg. 2020;47(4):301–4. https://doi.org/10.5999/aps.2020.00731.
Sundaram H, Voigts B, Beer K, Meland M. Comparison of the rheological properties of viscosity and elasticity in two categories of soft tissue fillers: calcium hydroxylapatite and hyaluronic acid. Dermatol Surg. 2010;36:1859–65.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Samizadeh, S., Samizadeh, S. (2022). Dermal Fillers: Understanding the Fundamentals. In: Samizadeh, S. (eds) Non-Surgical Rejuvenation of Asian Faces. Springer, Cham. https://doi.org/10.1007/978-3-030-84099-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-030-84099-0_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-84098-3
Online ISBN: 978-3-030-84099-0
eBook Packages: MedicineMedicine (R0)